US Broker Ratings

Chemed Corp (CHE) Stock Report: Navigating Valuation with a 25.60% ROE and a Modest Upside

Chemed Corp (NYSE: CHE) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Known for its diversified operations through..

Bio-Techne Corp (TECH) Stock Analysis: An Investor’s Look at 27% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a significant player in the biotechnology sector, is capturing investor attention with its robust market positioning and a promising potential upside of..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Biotechnology Innovator with 20.65% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with its cutting-edge focus on precision oncology. As a clinical-stage company, Revolution Medicines is..

Agilent Technologies (A) Stock Analysis: A Diagnostic Powerhouse with 40% Upside Potential

Agilent Technologies, Inc. (NYSE: A), a leader in the diagnostics and research industry, presents a compelling investment case with its robust market position and promising growth..

Corcept Therapeutics (CORT) Stock Analysis: Unveiling a Promising 31% Upside

For investors eyeing opportunities within the biopharmaceutical sector, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents an intriguing option. With a market capitalization of $6.46 billion, this biotechnology..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Biotech Player with 72% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a formidable player in the biotechnology sector, distinguished by its commitment to developing groundbreaking therapies for cancer treatment. With..

Becton, Dickinson and Company (BDX): Evaluating Growth Potential with a 24% Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to hold a commanding presence in the Medical Instruments & Supplies industry. With..

argenx SE (ARGX) Stock Analysis: Unveiling a 27% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector may find argenx SE (NASDAQ: ARGX) to be a compelling opportunity. With a market cap of $50.4..

Henry Schein, Inc. (HSIC) Stock Analysis: Healthcare Distributor with 17.52% Potential Upside

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the medical distribution industry, stands as a significant player in the healthcare sector with a market capitalization of..

The Cigna Group (CI) Stock Analysis: A Healthcare Giant with a Promising 19% Upside

For investors seeking opportunities in the healthcare sector, The Cigna Group (CI) presents a compelling case. With a robust market capitalization of $75.72 billion, Cigna operates..

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with 7.95% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to catch the eye of investors, presenting a potential upside of 7.95% based on..

BeOne Medicines Ltd. (ONC) Investor Outlook: A Biotech Powerhouse with a 32.64% Upside Potential

BeOne Medicines Ltd. (ONC), based in Basel, Switzerland, is making waves in the biotechnology sector with its robust pipeline of innovative cancer therapies. With a market..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genetic Sequencing Giant’s Potential with a 33.82% ROE

Illumina, Inc. (NASDAQ: ILMN) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Based in San Diego, California, the..

Encompass Health Corporation (EHC) Stock Analysis: A 35% Upside Potential Beckons Investors

Encompass Health Corporation (NYSE: EHC), a leader in the healthcare sector specializing in medical care facilities, presents an intriguing opportunity for investors with a potential upside..

BioNTech SE (BNTX) Investor Outlook: Navigating a 33% Potential Upside Amidst Biotech Volatility

BioNTech SE (NASDAQ: BNTX) has captured global attention, not only for its groundbreaking mRNA COVID-19 vaccine but also for its ambitious oncology pipeline. As investors consider..

Tenet Healthcare Corporation (THC) Stock Analysis: A 40% Upside Potential Beckons Investors

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. medical care facilities industry, presents a compelling opportunity for investors with its robust growth potential..

The Cooper Companies, Inc. (COO) Stock Analysis: Potential 45.59% Upside Driven by Healthcare Innovation

The Cooper Companies, Inc. (NYSE: COO) stands out in the healthcare sector with its innovative approach to medical instruments and supplies, particularly focusing on contact lenses..

ICON plc (ICLR) Stock Analysis: Unveiling a 13.55% Upside Potential for Investors

ICON plc (NASDAQ: ICLR), a leading clinical research organization based in Dublin, Ireland, is drawing the attention of savvy investors with its promising 13.55% potential upside...

Molina Healthcare Inc (MOH): Analyst Consensus and Stock Analysis Reveal Limited Upside Potential

Molina Healthcare Inc (NYSE: MOH) presents a mixed bag for investors, as its current financial and stock performance metrics reveal both challenges and opportunities in the..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a 12.69% Upside Potential and Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, specifically within the drug manufacturing industry, is a company that continues to capture the attention of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds